Keywords: MR-Guided Radiotherapy, MR-Guided Radiotherapy, oligometastatic prostate cancer
Motivation: MDT is promising for oligometastatic prostate cancer(omPC) and could have potential for better management of lymph node metastases(LNMs) through the use of MR-guided radiotherapy (MRgRT).
Goal(s): The primary goal is to quantitatively assess inter-fractional size changes of irradiated LNMs during MRgRT and evaluate their clinical implications for treatment adaptation.
Approach: We analyzed 42 LNMs across 14 patients, measuring size changes via daily MRI scans during a 5-fraction MRgSBRT treatment regimen.
Results: Results showed a significant trend of size reduction in most LNMs, with 57.1% of patients exhibiting substantial changes that influenced online treatment adaptations, suggesting potential prognostic value for MRgSBRT outcomes.
Impact: The study's findings could enhance clinical practices in managing LNMs in omPC, prompting further investigations into the prognostic value of inter-fractional size changes. This research may lead to improved treatment strategies and personalized approaches, ultimately benefiting patient outcomes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords